HalioDx SAS

Series A Round Brings $60m To 89bio Launched with small molecules licensed from Teva Pharmaceutical Industries Ltd. , 89bio concurrently raised $60m through its Series A round. Founding investors O

Shortly after arriving at University of California, San Diego as its director of commercialization, Ruben Dario Flores-Saaib initiated an “entrepreneurs in residence” program that in two years helpe

Below is Scrip ’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Unite

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio